γδ T cells and resistance to CDK4/6 inhibitors in breast cancer

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2025-11-14
DOI
https://doi.org/10.1038/s41419-025-08149-z
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

γδ T cells and resistance to CDK4/6 inhibitors in breast cancer

Oliver Kepp, Guido Kroemer
Cell Death and Disease
Advanced Breast Cancer Therapies
article

γδ T cells and resistance to CDK4/6 inhibitors in breast cancer

Oliver Kepp, Guido Kroemer
article en

Abstract

No abstract available for this paper.
Cell Death and DiseaseVol. 16(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université Paris Cité (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Sorbonne Université (FR), Centre de Recherche des Cordeliers (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen (FR)
Association pour la Recherche sur le Cancer, Seerave Foundation, Equipex, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, Institut Universitaire de France, Institut National Du Cancer, Institut Gustave-Roussy, Direction Générale de l’offre de Soins, Ministère des Solidarités et de la Santé, Fondation Gustave Roussy, Université de Paris, HORIZON EUROPE European Innovation Council
Openalex Percentile: Top 51%
Advanced Breast Cancer Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.